Adequate level of Vitamin D is essential for maintaining good health;Włas̈ciwy poziom witaminy D warunkiem zachowania zdrowia

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 62, Issue , 2008, Pages 502-510

  Tukaj, Cecylia ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Chronic diseases; Deficiency; Metabolism; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; DRUG DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN D;

AUTOIMMUNE DISEASE; BIOSYNTHESIS; CALCIUM INTAKE; COMORBIDITY; DIET SUPPLEMENTATION; EPIDEMIOLOGY; HUMAN; KIDNEY; METABOLISM; NEOPLASM; OSTEOPOROSIS; REVIEW; SUNLIGHT; VITAMIN D DEFICIENCY;

AUTOIMMUNE DISEASES; CALCIUM; CALCIUM, DIETARY; CAUSALITY; CHOLECALCIFEROL; COMORBIDITY; DIETARY SUPPLEMENTS; HUMANS; KIDNEY; NEOPLASMS; OSTEOPOROSIS; SUNLIGHT; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 60649108110     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Adorini L.: Immunomodulatory effects of Vitamin D receptor ligands in autoimmune diseases. Int. Immunopharmacol., 2002; 2: 1017-1028
2. Alpert P.T., Shaikh U.: The effects of Vitamin D deficiency and insufficiency on the endocrine and paracrine systems. Biol. Res. Nurs., 2007; 9: 117-129
3. Armas L.A., Dowell S., Akhter M., Duthuluru S., Huerter C., Hollis B.W., Lund R., Heaney R.P.: Ultraviolet-B radiation increases serum 25-hydroxyVitamin D levels: The effect of UVB dose and skin color. J. Am. Acad. Dermatol., 2007; 57: 588-593
4. Armas L.A., Hollis B., Heaney R.P.: Vitamin D2 is much less effective than Vitamin D3 in humans. J. Clin. Endocrinol. Metab., 2004; 89: 5387-5391
5. Bischoff-Ferrari H.A., Dietrich T., Orav E., Dawson-Hughes B:. Positive association between 25(OH)D levels and bone mineral density: A population-based study of younger and older adults. Am. J. Med., 2004; 116: 634-639
6. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson-Hughes B.: Estimation of optimal serum concentrations of 25-hydroxyVitamin D for multiple health outcomes. Am. J. Clin. Nutr., 2006; 84: 18-28
7. Boonen S., Bischoff-Ferrari H.A, Cooper C., Lips P., Ljunggren O., Meunier P.J, Reginster J.Y.: Addressing the musculoskeletal components of fracture risk with calcium and Vitamin D: A review of the evidence. Calcif. Tissue Int. 2006; 78: 257-270
8. Cannell J.J., Hollis B.W.: Use of Vitamin D in clinical practice. Altern. Med. Rev., 2008, 13: 6-20
9. Cantorna M.T., Zhu Y., Froicu M., Wittke A.: Vitamin D status, 1,25-dihydroxyVitamin D3, and the immune system. Am. J. Clin. Nutr., 2004; 8: 1717S-1720S
10. Cashman K.D.: Vitamin D in childhood and adolescence. Postgrad. Med. J., 2007, 83: 230-235
11. Chen T.C., Chimeh F., Lu Z., Mathieu J., Person K.S., Zhang A., Kohn N., Martinello S., Berkowitz R., Holick M.F.: Factors that influence the cutaneous synthesis and dietary sources of Vitamin D. Arch. Biochem. Biophys., 2007; 460: 213-217
12. Clemens T.L., Adams J.S., Henderson S.L., Holick M.F.: Increased skin pigment reduces the capacity of skin to synthesize Vitamin D3. Lancet, 1982; 9: 74-76
13. Dawson-Hughes B., Harris S.S., Krall E.A., Dallal G.E.: Effect of calcium and Vitamin D supplementation on bone density in men and women 65 years of age or older.: N. Engl. J. Med., 1997; 337: 670-676
14. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J., Vieth R.: Estimates of optimal Vitamin D status. Osteoporos. Int., 2005; 16: 713-716
15. DeLuca H.F.: Overview of general physiologic features and functions of Vitamin D. Am. J. Clin. Nutr., 2004; 80: 1689S-1696S
16. DeLuca H.F., Cantorna M.: Vitamin D: its role and uses in immunology. FASEB J., 2001; 15: 2579-2585
17. Dusso A.S., Brown A.J., Slatopolsky E.: Vitamin D. Am. J. Physiol. Renal Physiol., 2005; 289: F8-F28
18. Garland C.F, Garland F.C., Gorham E.D., Grant W., Garland F.: The role of Vitamin D in cancer prevention. Am. J. Public Health, 2006; 96: 252-561
19. Garland C.F., Gorham E.D., Mohr S., Grant W., Giovannucci E., Lipkin M., Newmark H., Holick M., Garland F.: Vitamin D and prevention of breast cancer: pooled analysis. J. Steroid Biochem. Mol. Biol., 2007, 103: 708-711
20. Giovannucci E.: Vitamin D status and cancer incidence and mortality. Adv. Exp. Med. Biol., 2008; 624: 31-42
21. Glerup H., Mikkelsen K., Poulsen L., Hass E., Overbeck S., Thomsen J., Charles P., Eriksen E.F.:Commonly recommended daily intake of Vitamin D is not sufficient if sunlight exposure is limited. J. Intern. Med., 2000; 247: 260-268
22. Gloth F.M., Gundberg C., Hollis B., Haddad J.G. Jr, Tobin J.: Vitamin D deficiency in homebound elderly persons. JAMA, 1995; 274: 1683-1686
23. Gordon C.M., DePeter K.C., Feldman H.A., Grace E., Emans S.J.: Prevalence of Vitamin D deficiency among healthy adolescents. Arch. Pediatr. Adolesc. Med., 2004; 158: 531-537
24. Gorham E.D., Garland C.F., Garland F.C., Grant W.B., Mohr S.B., Lipkin., Newmark H.L., Giovannucci E., Wei M., Holick M.F.: Optimal Vitamin D status for colorectal cancer prevention: A quantitative meta analysis. Am. J. Prev. Med., 2007, 32: 210-216
25. Guillemant J., Le H.T., Maria A., Allemandu A., Peres G., Guillemant S.: Wintertime Vitamin D deficiency in male adolescents: effect on parathyroid function and response to Vitamin D3 supplements. Osteoporos. Int., 2001, 12: 875-879
26. Hathcock J.N., Shao A., Vieth R., Heaney R.: Risk assessment for Vitamin D. Am. J. Clin. Nutr., 2007; 85: 6-18
27. Haussler M.R., Jurutka P.W., Hsieh J.C., Thompson P.D, Selznick S.H, Haussler C.A, Whitfield G.K: New understanding of the molecular mechanism of receptor-mediated genomic actions of the Vitamin D hormone. Bone, 1995; 17: 33S-38S
28. Haussler M.R., Norman A.: Chromosomal receptor for a Vitamin D metabolite. Proc. Natl. Acad. Sci. USA, 1969; 62: 155-162
29. Haussler M.R., Whitfield G.K., Haussler C., Hsieh J.C., Thompson P.D., Selznick S.H., Dominguez C.E., Jurutka P.W.: The nuclear Vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Res., 1998; 13: 325-349
30. Heaney R.P.: The Vitamin D requirement in health and disease. J. Steroid Biochem. Mol. Biol., 2005; 97: 13-19
31. Heaney R.P., Davies K., Chen T., Holick M.F., Barger-Lux M.: Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr., 2003; 77: 204-210
32. Heaney R.P., Dowell M.S., Hale C.A., Bendich A:. Calcium absorption varies within the reference range for serum 25-hydroxyVitamin D. J. Am. Coll. Nutr., 2003; 22: 142-146
33. Holick M.F.:Vitamin D: A millenium perspective. J. Cell Biochem., 2003; 88: 296-307
34. Holick M.F.: Sunlight and Vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr., 2004; 80: 1678S-1688S
35. Holick M.F.: Resurrection of Vitamin D deficiency and rickets J. Clin. Invest., 2006; 116: 2062-2072
36. Holick M.F.: High prevalence of Vitamin D inadequacy and implications for health. Mayo Clin. Proc., 2006; 81: 353-373
37. Holick M.F.: Vitamin D deficiency. N. Engl. J. Med., 2007; 357: 266-281
38. Hollis B.W.: Circulating 25-ydroxyVitamin D levels indicative of Vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for Vitamin D. J. Nutr., 2005; 135: 317-322
39. Hypponen E., Laara E., Reunanen A, Jarvelin M.R., Virtanen S.M.: Intake of Vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet, 2001; 358: 1500-1503
40. Jablonski N.G., Chaplin G.: The evolution of human skin coloration. J. Hum. Evol., 2000; 39: 57-106
41. Jones G.: Expanding role for Vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyVitamin D(3). Semin. Dial., 2007; 20: 316-324
42. Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.P., Heaney R.P.: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr., 2007; 85: 1586-1591
43. Lee J.M., Smith J.R., Philipp B.L., Chen T.C, Mathieu J., Holick M.F.: Vitamin D deficiency in a healthy group of mothers and newborn infants. Clin. Pediatr. (Phila), 2007; 46: 42-44
44. Li Y.C.: Vitamin D regulation of the renin-angiotensin system. J. Cell Biochem., 2003; 88: 327-331
45. Lips P.: Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr. Rev., 2001; 22: 477-501
46. Lips P.: Vitamin D physiology. Prog. Biophys. Mol. Biol., 2006; 92: 4-8
47. Lips P., Hosking D., Lippuner K., Norgquist J.M., Wehren L., Maalouf G., Ragi-Eis S., Chandler J.: The prevalence of Vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J. Intern. Med., 2006; 260: 245-254
48. Losel R.M., Falkenstein E., Feuring M., Schultz A., Tillmann H., Rossol-Haseroth K., Wehling M.: Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev,. 2003; 83: 965-1016
49. MacLaughlin J.A., Anderson R.R., Holick M.F.: Spectral character of sunlight modulates photosynthesis of preVitamin D3 and its photoisomers in human skin. Science, 1982; 216: 1001-1004
50. Mathieu C., Adorini L.: The coming of age of 1,25-dihydroxyVitamin D3 analogs as immunomodulatory agents. Trends Mol. Med., 2002; 8: 174-179
51. Matsuoka L.Y., Wortsman J., Haddad J.G., Hollis BW.: In vivo threshold for cutaneous synthesis of Vitamin D3. J. Lab. Clin. Med., 1989; 114: 301-305
52. McCollum E.V., Simmonds N., Becker J.E., Shipley P.G.: Studies on experimental rickets; and experimental demonstration of the existence of a vitamin which promotes calcium deposition. J. Biol. Chem.,1922; 53: 293-312
53. McGrath J., Selten J.P., Chant D.: Long term trends in sunshine duration and its association with schizophrenia birth rates and age at first registration-data from Australia and the Netherlands. Schizophr. Res., 2002; 54: 199-212
54. Mellanby T.: The part played by an "accessory factor" in the production of experimental rickets. J. Physiol., 1918; 52: 11-14
55. Mohr S.B., Garland C.F., Gorham E.D., Grant W.B., Garland F.C.: Could ultraviolet B irradiance and Vitamin D be associated with lower incidence rates of lung cancer? J. Epidemiol. Community Health, 2008; 62: 69-74
56. Nagpal S., Na S., Rathnachalam R.: Noncalcemic action of Vitamin D receptor ligands. Endocr. Rev., 2005; 26: 662-687
57. Nemere I., Yoshimoto Y., Norman A.W: Calcium transport in perfused duodena from normal chicks: enhancement within fourteen minutes of exposure to 1,25-dihydroxyVitamin D3. Endocrinology, 1984; 115: 1476-1483
58. Norman A.W.: Evidence for a new kidney-produced hormone, 1,25-dihydroxycholecalciferol, the proposed biologically active form of Vitamin D. Am J Clin Nutr., 1971; 24: 1346-1351
59. Norman A.W.: Minireview: Vitamin D receptor: new assignments for an already busy receptor. Endocrinology, 2006; 147: 5542-5548
60. Peterlik M., Cross H.S.: Vitamin D and calcium deficits prdispose for multiple chronic diseases. Eur. J. Clin. Invest., 2005; 35: 290-304
61. Pike J.W.: Vitamin D3 receptors:structure and function in transcription. Annu. Rev. Nutr., 1991; 11: 189-216
62. Plotnikoff G.A., Quigley J.M.: Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin. Proc., 2003; 78: 1463-1470
63. Ponsonby A.L, McMichael A., van der Mei I.: Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology, 2002; 181-182: 71-78
64. Prosser D.E, Jones G.: Enzymes involved in the activation and inactivation of Vitamin D, Trends Biochem. Sci., 2004; 29: 664-673
65. Reichel H., Koeffler H.P., Norman A.W.: The role of the Vitamin D endocrine system in health and disease. N. Engl. J. Med., 1989; 320: 980-991
66. Rostand SG.: Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension, 1997; 30: 150-156
67. Shimada T., Hasegawa H., Yamazaki Y., MutoT., Hino R., Fujita T., Nakahara K., Fukumoto S., Yamashita T.: FGF-23 is a potent regulator of Vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res., 2004; 19: 429-435
68. Somjen D., Weisman Y., Kohen F., Gayer B., Limor R., Sharon O., Jaccard N., Knoll E., Stern N.: 25-HydroxyVitamin D3-1a hydroxylase is expressed in human vascular smooth muscle cells and is up regulated by parathyroid hormone and estrogenic compounds. Circulation, 2005; 111: 1666-1672
69. Stumpf W.E., Sar M., Reid F.A., Tanaka Y., DeLuca H.F.: Target cells for 1,25-dihydroxyVitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science, 1979; 206: 1188-1190
70. Tangpricha V., Turner A., Spina C., Decastro S., Chen T.C., Holick M.F.: Tanning is associated with optimal Vitamin D status (serum 25-hydroxyVitamin D concentration) and higher bone mineral density. Am. J. Clin. Nutr., 2004; 80: 1645-1649
71. Taskapan H., Wei M., Oreopoulos D.G.: 25(OH) Vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int. Urol. Nephrol., 2006; 38: 323-329
72. Vieth R.: Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J. Steroid Biochem. Mol. Biol., 2004; 89-90: 575-579
73. Vieth R., Ladak Y., Walfish P.G.: Age-related changes in the 25-hydroxyVitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more Vitamin D. J. Clin. Endocrinol. Metab., 2003; 88: 185-191
74. Webb A.R., Kline L., Holick M.F.: Influence of season and latitude on the cutaneous synthesis of Vitamin D3 synthesis in human skin. J. Clin. Endocrinol. Metab., 1988; 67: 373-378
75. Whiting S.J., Calvo M.S.: Dietary recommendations for Vitamin D: A critical need for functional end points to establish an estimated average requirement. J. Nutr., 2005; 135: 304-309
76. Wolf G.: The discovery of Vitamin D: The contribution of Adolf Windaus. J. Nutr., 2004; 134: 1299-1302
77. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., Holick M.F.: Decresed bioavailability of Vitamin D in obesity. Am. J. Clin. Nutr., 2000; 72: 690-693
78. Zehnder D., Bland R., Williams M.C., McNinch R.W., Howie A.J., Stewart P.M., Hewison M.: Extrarenal expression of 25-hydroxyVitamin D3-1a-hydroxylase. J. Clin. Endocrinol. Metab., 2001; 86: 888-894
79. Zittermann A.: Vitamin D and disease prevention with special reference to cardiovascular disease. Prog. Biophys. Mol. Biol., 2006; 92: 39-48